Implications of blood soluble and cell surface tumor necrosis factor receptors in childhood nephrotic syndrome

Pediatric Nephrology

Volumn 17, Issue 11, 2002, Pages 926-932

  Tain, You Lin ^a   Liu, Chieh An ^a,b   Yang, Kuender D ^a,b,c  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

Cell surface tumor necrosis factor receptor (cTNFR); Nephrotic syndrome; Soluble tumor necrosis factor receptor (sTNFR); Steroid resistant

Indexed keywords

CELL SURFACE RECEPTOR; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ARTICLE; CELL SURFACE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG SENSITIVITY; EARLY DIAGNOSIS; GRANULOCYTE; HUMAN; IDIOPATHIC DISEASE; INFANT; LEUKOCYTE; LYMPHOCYTE; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; LYMPHOCYTES; MALE; NEPHROTIC SYNDROME; PREDNISOLONE; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; STEROIDS;

EID: 0036952994     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-002-0994-z     Document Type: Article

References (35)

1. Webb NJ, Lewis MA, Iqbal J, Smart PJ, Lendon M, Postlethwaite RJ (1996) Childhood steroid-sensitive nephrotic syndrome: does the histology matter? Am J Kidney Dis 27:484-488
2. Frishberg Y, Rinat C, Megged O, Shapira E, Feinstein S, Raas-Rothschild A (2002) Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. J Am Soc Nephrol 13:400-405
3. Egido J (1993) Role of tumor necrosis factor-α in the pathogenesis of glomerular disease. Kidney Int 43:S59-S64
4. McCarthy ET, Sharma R, Sharma M, Li JZ, Ge XL, Dileezpan KN, Savin VJ (1998) TNF-α increases albumin permeability of isolated rat glomeruli through the generation of superoxide. J Am Soc Nephrol 9:433-438
5. Ozen S, Saatci U, Tinaztepe K, Bakkaloglu A, Barut A (1994) Urinary tumor necrosis factor levels in primary glomerulonephritis. Nephron 66:291-294
6. Suranyi MG, Guasch A, Hall BM, Myers BD (1993) Elevated levels of tumor necrosis factor-α in the nephrotic syndrome in humans. Am J Kidney Dis 21:251-259
7. Hale KK, Smith CG, Baker SL, Vanderslice RW, Squires CH, Gleason TM, Tucker KK, Kohno T, Russell DA (1995) Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. Cytokine 7:26-38
8. Han J, Thomson P, Beutler B (1990) Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 172:391-394
9. Chambaut-Guerin AM, Thomopoulos P (1991) Regulation by dexamethasone and 1,25-dihydroxyvitamin D3 of the 75 kd-type A tumor necrosis factor receptor surface expression and mRNA level in human U937 cells. Eur Cytokine Netw 2:355-360
10. Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarna K (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 370:218-220
11. Gattorno M, Picco P, Barbano G, Stalla F, Sormani MP, Buoncompagni A, Gusmano R, Borrone C, Pistoia V (1998) Differences in tumor necrosis factor-α soluble receptor serum concentrations between patients with Henoch-Schonlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications. J Rheumatol 25:361-365
12. Dorge SE, Roux-Lombard P, Dayer JM, Koch KM, Frei U, Lonnemann G (1994) Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients. Transplantation 58:1000-1008
13. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329
14. Ortiz A, Bustos C, Alonso J, Alcazar R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, Egido J (1995) Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. Adv Nephrol Necker Hosp 24:53-77
15. Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M, Pilatte Y (1998) Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy? Clin Exp Immunol 114:468-476
16. Aderka D, Wysenbeek A, Engelmann H, Cope AP, Brennan F, Molad Y, Hornik V, Levo Y, Maini RN, Feldmann M (1993) Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 36:1111-1120
17. Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, Maxwell RJ, Rowlands BJ (1995) Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 36:897-901
18. Jutley RS, Youngson GG, Eremin O, Ninan GK (2000) Serum cytokine profile in reflux nephropathy. Pediatr Surg Int 16:64-68
19. Jablonska E, Jablonski J, Holownia A (1999) Role of neutrophils in release of some cytokines and their soluble receptors. Immunol Lett 70:191-197
20. Schleiffenbaum B, Fehr J (1990) The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factor-induced neutrophil responses by receptor down-regulation. J Clin Invest 86:184-195
21. Fiser RT, Arnold WC, Charlton RK, Steele RW, Childress SH, Shirkey B (1991) T-lymphocyte subsets in nephrotic syndrome. Kidney Int 40:913-916
22. Tani Y, Kida H, Abe T, Tomosugi N, Saito Y, Asamoto T, Hattori N (1982) B lymphocyte subset patterns and their significance in idiopathic glomerulonephritis. Clin Exp Immunol 48:201-204
23. Yang MY, Chuang H, Chen RF, Yang KD (2002) Reversible phosphatidylserine expression on blood granulocytes related to membrane perturbation but not DNA strand breaks. J Leukoc Biol 71:231-237
24. Yang KD, Liou WY, Lee CS, Chu ML, Shaio MF (1992) Effects of phenobarbital on leukocyte activation: membrane potential, actin polymerization, chemotaxis, respiratory burst, cytokine production, and lymphocyte proliferation. J Leukoc Biol 52:151-156
25. Koukouritakin SB, Vardaki EA, Papakonstanti EA, Lianos E, Stournaras C, Emmanouel DS (1999) TNF-alpha induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase. Mol Med 5:382-392
26. Bustos C, Gonzalez E, Muley R, Alonso JL, Egido J (1994) Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 24:799-805
27. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A 88:9292-9296
28. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr. (1985) Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol 135:2069-2073
29. Berens KL, Verani RR, Luke DR (1998) Role of neutrophils and macrophages in experimental nephrosis of the rat. Ren Fail 20:53-63
30. Poll T van der, Coyle SM, Kumar A, Barbosa K, Agosti JM, Lowry SF (1997) Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia: effect of neutralization of endotoxin-induced TNF activity by infusion of a recombinant dimeric TNF receptor. J Immunol 158:1490-1497
31. Hubl W, Wolfbauer G, Streicher J, Andert S, Stanek G, Fitzal S, Bayer PM (1999) Differential expression of tumor necrosis factor receptor subtypes on leukocytes in systemic inflammatory response syndrome. Crit Care Med 27:319-324
32. Tartaglia LA, Pennica D, Goeddel DV (1993) Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18542-18548
33. Hohmann HP, Remy R, Brockhaus M, Loon AP van (1989) Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 264:14927-14934
34. Schroder J, Stuber F, Gallati H, Schade FU, Kremer B (1995) Pattern of soluble TNF receptors I and II in sepsis. Infection 23:143-148
35. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF (1992) Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A 89:4845-4849